Watchdog approves ovarian cancer treatment
NICE approves rucaparib for use on NHS Related items fromOnMedica Drug for hereditary ovarian cancer approved Cancer drugs to be re-evaluated Red tape delaying availability of new cancer drugs Is crowdfunding for cancer patients paying for ‘quackery’? NICE rejects breast cancer drug for NHS funding
Source: OnMedica Latest News - Category: UK Health Source Type: news
More News: Breast Cancer | Cancer | Cancer & Oncology | Funding | National Institute for Health and Clinical Excelle | Ovarian Cancer | Ovaries | UK Health